News and Insights of 3D Printing and Manufacturing
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be working with collaborators at two of the world’s largest pharmaceutical companies Merck and GSK, as well as McGill University’s Goodman Cancer Research Centre in Quebec.
The 3D BioFabrication Facility (BFF) bioprinter from nScrypt, a Florida-based 3D printing system manufacturer, and spaceflight equipment developer Techshot is set to launch on the International Space Station (ISS) next month.
Structo, a Singapore based dental 3D printer OEM has partnered with California based digital dentistry company uLab Systems to streamline the production of orthodontic clear aligners.
California-based institutions Transcriptic, a robotic cloud laboratory platform, and 3Scan, a digital 3D tissue model specialist, have announced a merger to form the company Strateos.
Korean biotechnology companies T&R Biofab and SCM Life Science are to collaborate on the R&D of new 3D printed tissue regenerative products. The two companies will focus on marketable cell patch products and new formulations for cell therapy.
Aleph Objects, the manufacturer of LulzBot open source 3D printers, has confirmed its entry into the 3D bioprinting market. In partnership with Massachusetts based 3D bioprinting technology developer FluidForm, Aleph plans to launch LulzBot Bio hardware later this year.
As 3D printing evolves and matures, so to do the expectations surrounding it. In order to meet these growing expectations and to address an increasing number of use cases for 3D printing—in prototyping and end-use production—it is important to recognize that the 3D printer itself is just part of the equation. A key element is also material selection, in this case SLS powder materials.
Global medical technology firm Stryker, that has rapidly become a leader in 3D printed titanium implants, has announced plans to invest €200 million (approximately $225.8 million) for expansion of it’s R&D facilities in the Irish city of Cork.
California-based medical 3D printing service bureau PrinterPrezz has partnered with UCSF Surgical Innovations, an incubator-accelerator for medtech innovators at UC San Francisco.
Belgian 3D printing software company Materialise has received FDA approval for Mimics Enlight, a 3D modeling software for planning cardiovascular surgery.